Dynavax Technologies CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Deep Track Capital and its affiliates have reported a complete divestment of their beneficial ownership in Dynavax Technologies Corporation, reducing their stake to 0%.
Deep Track Biotechnology Master Fund, Ltd., Deep Track Capital, LP, and David Kroin have filed an amended Schedule 13G, reporting a 13.41% passive beneficial ownership in Dynavax Technologies Corporation.
SCHEDULE 13G/A: BlackRock Discloses 14.2% Passive Stake in Dynavax Technologies
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.2% beneficial ownership stake in Dynavax Technologies Corp., primarily for passive investment purposes.
Kynam Capital Management, LP, along with its general partner and managing member, Yue Tang, has disclosed a beneficial ownership of 4.99% in Dynavax Technologies Corp. common stock as of December 31, 2024.